Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc.
Your view on RPID
Overview
What the company does, where it operates, and who runs it.
About Rapid Micro Biosystems, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Robert G. Spignesi Jr.
- Headquarters
- 1001 Pawtucket Boulevard West, Lowell, MA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Robert G. Spignesi Jr.
- Headquarters
- 1001 Pawtucket Boulevard West, Lowell, MA, US
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.
The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.
Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services.
Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007.
Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Rapid Micro Biosystems, Inc., and the rating behind it. RPID last traded at $1.23; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Rapid Micro Biosystems, Inc.. Starting points for Rapid Micro Biosystems, Inc.: EPS -$1.09, beta 1.44 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Rapid Micro Biosystems, Inc.. Rapid Micro Biosystems, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Rapid Micro Biosystems, Inc.. Trailing twelve-month EPS for Rapid Micro Biosystems, Inc. stands at -$1.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Rapid Micro Biosystems, Inc.. Rapid Micro Biosystems, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Rapid Micro Biosystems, Inc. valued side by side against its closest peers. Rapid Micro Biosystems, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Rapid Micro Biosystems, Inc., and how their positions are changing. At a $55.7M market value, institutional positions materially move Rapid Micro Biosystems, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Rapid Micro Biosystems, Inc. executives and directors. Shares of Rapid Micro Biosystems, Inc. have traded between $0.87 and $4.50 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Rapid Micro Biosystems, Inc.. Rapid Micro Biosystems, Inc. is a $55.7M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Rapid Micro Biosystems, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Rapid Micro Biosystems, Inc.. Coverage tracks Rapid Micro Biosystems, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.